APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gene Therapy Products

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Gene Therapy Products Industry Growth and Trends Forecast to 2032

19 December 202598 pages

Choose your research edition.

Industry ResearchGene Therapy Products Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Gene Therapy Products Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Gene Therapy Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gene Therapy Products Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Gene Therapy Products Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Gene Therapy Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Gene Therapy Products is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Gene Therapy Products is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gene Therapy Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gene Therapy Products include Advantagene, Avalanche Bio, Bluebird Bio, Celladon, Dimension Therapeutics, Sangamo, Spark Therapeutics and Vical Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Gene Therapy Products market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Gene Therapy Products market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Gene Therapy Products market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Gene Therapy Products.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Gene Therapy Products market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Gene Therapy Products Market by Company

Advantagene

Avalanche Bio

Bluebird Bio

Celladon

Dimension Therapeutics

Sangamo

Spark Therapeutics

Vical Inc.

Gene Therapy Products Segment by Type

Ex vivo

In Vivo

Gene Therapy Products Segment by Application

Cardiovascular disease

Monogenic

Infectious disease

Cancer

Other

Gene Therapy Products Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Therapy Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gene Therapy Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Therapy Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gene Therapy Products manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Gene Therapy Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Ex vivo Table 2. Major Company of In Vivo Table 3. Global Gene Therapy Products Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Gene Therapy Products Sales by Type (2021-2026) & (K Units) Table 5. Global Gene Therapy Products Sales Market Share in Volume by Type (2021-2026) Table 6. Global Gene Therapy Products Sales by Type (2021-2026) & (US$ Million) Table 7. Global Gene Therapy Products Sales Market Share in Value by Type (2021-2026) Table 8. Global Gene Therapy Products Price by Type (2021-2026) & (US$/Unit) Table 9. Global Gene Therapy Products Sales by Type (2027-2032) & (K Units) Table 10. Global Gene Therapy Products Sales Market Share in Volume by Type (2027-2032) Table 11. Global Gene Therapy Products Sales by Type (2027-2032) & (US$ Million) Table 12. Global Gene Therapy Products Sales Market Share in Value by Type (2027-2032) Table 13. Global Gene Therapy Products Price by Type (2027-2032) & (US$/Unit) Table 14. North America Gene Therapy Products Sales by Type (2021-2026) & (K Units) Table 15. North America Gene Therapy Products Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Gene Therapy Products Sales by Type (2021-2026) & (K Units) Table 17. Europe Gene Therapy Products Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Gene Therapy Products Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Gene Therapy Products Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Gene Therapy Products Sales by Type (2021-2026) & (K Units) Table 21. Latin America Gene Therapy Products Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Gene Therapy Products Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Gene Therapy Products Sales by Type (2021-2026) & (US$ Million) Table 24. Gene Therapy Products Industry Trends Table 25. Gene Therapy Products Industry Drivers Table 26. Gene Therapy Products Industry Opportunities and Challenges Table 27. Gene Therapy Products Industry Restraints Table 28. Global Gene Therapy Products Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Gene Therapy Products Revenue Market Share by Company (2021-2026) Table 30. Global Gene Therapy Products Sales by Company (2021-2026) & (K Units) Table 31. Global Gene Therapy Products Sales Share by Company (2021-2026) Table 32. Global Gene Therapy Products Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Gene Therapy Products Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Gene Therapy Products Major Company Production Sites and Headquarters Table 35. Global Gene Therapy Products Company, Product Type & Application Table 36. Global Gene Therapy Products Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Gene Therapy Products by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Gene Therapy Products Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Gene Therapy Products Sales by Region (2021-2026) & (K Units) Table 41. Global Gene Therapy Products Sales Market Share in Volume by Region (2021-2026) Table 42. Global Gene Therapy Products Sales by Region (2021-2026) & (US$ Million) Table 43. Global Gene Therapy Products Sales Market Share in Value by Region (2021-2026) Table 44. Global Gene Therapy Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Gene Therapy Products Sales by Region (2027-2032) & (K Units) Table 46. Global Gene Therapy Products Sales Market Share in Volume by Region (2027-2032) Table 47. Global Gene Therapy Products Sales by Region (2027-2032) & (US$ Million) Table 48. Global Gene Therapy Products Sales Market Share in Value by Region (2027-2032) Table 49. Global Gene Therapy Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Gene Therapy Products Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Gene Therapy Products Sales by Application (2021-2026) & (K Units) Table 52. Global Gene Therapy Products Sales Market Share in Volume by Application (2021-2026) Table 53. Global Gene Therapy Products Sales by Application (2021-2026) & (US$ Million) Table 54. Global Gene Therapy Products Sales Market Share in Value by Application (2021-2026) Table 55. Global Gene Therapy Products Price by Application (2021-2026) & (US$/Unit) Table 56. Global Gene Therapy Products Sales by Application (2027-2032) & (K Units) Table 57. Global Gene Therapy Products Sales Market Share in Volume by Application (2027-2032) Table 58. Global Gene Therapy Products Sales by Application (2027-2032) & (US$ Million) Table 59. Global Gene Therapy Products Sales Market Share in Value by Application (2027-2032) Table 60. Global Gene Therapy Products Price by Application (2027-2032) & (US$/Unit) Table 61. North America Gene Therapy Products Sales by Application (2021-2026) & (K Units) Table 62. North America Gene Therapy Products Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Gene Therapy Products Sales by Application (2021-2026) & (K Units) Table 64. Europe Gene Therapy Products Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Gene Therapy Products Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Gene Therapy Products Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Gene Therapy Products Sales by Application (2021-2026) & (K Units) Table 68. Latin America Gene Therapy Products Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Gene Therapy Products Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Gene Therapy Products Sales by Application (2021-2026) & (US$ Million) Table 71. Advantagene Company Information Table 72. Advantagene Business Overview Table 73. Advantagene Gene Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Advantagene Gene Therapy Products Product Portfolio Table 75. Advantagene Recent Development Table 76. Avalanche Bio Company Information Table 77. Avalanche Bio Business Overview Table 78. Avalanche Bio Gene Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Avalanche Bio Gene Therapy Products Product Portfolio Table 80. Avalanche Bio Recent Development Table 81. Bluebird Bio Company Information Table 82. Bluebird Bio Business Overview Table 83. Bluebird Bio Gene Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Bluebird Bio Gene Therapy Products Product Portfolio Table 85. Bluebird Bio Recent Development Table 86. Celladon Company Information Table 87. Celladon Business Overview Table 88. Celladon Gene Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Celladon Gene Therapy Products Product Portfolio Table 90. Celladon Recent Development Table 91. Dimension Therapeutics Company Information Table 92. Dimension Therapeutics Business Overview Table 93. Dimension Therapeutics Gene Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Dimension Therapeutics Gene Therapy Products Product Portfolio Table 95. Dimension Therapeutics Recent Development Table 96. Sangamo Company Information Table 97. Sangamo Business Overview Table 98. Sangamo Gene Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Sangamo Gene Therapy Products Product Portfolio Table 100. Sangamo Recent Development Table 101. Spark Therapeutics Company Information Table 102. Spark Therapeutics Business Overview Table 103. Spark Therapeutics Gene Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Spark Therapeutics Gene Therapy Products Product Portfolio Table 105. Spark Therapeutics Recent Development Table 106. Vical Inc. Company Information Table 107. Vical Inc. Business Overview Table 108. Vical Inc. Gene Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Vical Inc. Gene Therapy Products Product Portfolio Table 110. Vical Inc. Recent Development Table 111. North America Gene Therapy Products Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. North America Gene Therapy Products Sales by Country (2021-2026) & (K Units) Table 113. North America Gene Therapy Products Sales Market Share by Country (2021-2026) Table 114. North America Gene Therapy Products Sales Forecast by Country (2027-2032) & (K Units) Table 115. North America Gene Therapy Products Sales Market Share Forecast by Country (2027-2032) Table 116. North America Gene Therapy Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Gene Therapy Products Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Gene Therapy Products Market Share by Country (2021-2026) Table 119. North America Gene Therapy Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Gene Therapy Products Market Share Forecast by Country (2027-2032) Table 121. Europe Gene Therapy Products Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Europe Gene Therapy Products Sales by Country (2021-2026) & (K Units) Table 123. Europe Gene Therapy Products Sales Market Share by Country (2021-2026) Table 124. Europe Gene Therapy Products Sales Forecast by Country (2027-2032) & (K Units) Table 125. Europe Gene Therapy Products Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Gene Therapy Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Gene Therapy Products Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Gene Therapy Products Market Share by Country (2021-2026) Table 129. Europe Gene Therapy Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Gene Therapy Products Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Gene Therapy Products Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Gene Therapy Products Sales by Country (2021-2026) & (K Units) Table 133. Asia-Pacific Gene Therapy Products Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Gene Therapy Products Sales Forecast by Country (2027-2032) & (K Units) Table 135. Asia-Pacific Gene Therapy Products Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Gene Therapy Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Gene Therapy Products Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Gene Therapy Products Market Share by Country (2021-2026) Table 139. Asia-Pacific Gene Therapy Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Gene Therapy Products Market Share Forecast by Country (2027-2032) Table 141. Latin America Gene Therapy Products Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Latin America Gene Therapy Products Sales by Country (2021-2026) & (K Units) Table 143. Latin America Gene Therapy Products Sales Market Share by Country (2021-2026) Table 144. Latin America Gene Therapy Products Sales Forecast by Country (2027-2032) & (K Units) Table 145. Latin America Gene Therapy Products Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Gene Therapy Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Gene Therapy Products Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Gene Therapy Products Market Share by Country (2021-2026) Table 149. Latin America Gene Therapy Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Gene Therapy Products Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Gene Therapy Products Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Gene Therapy Products Sales by Country (2021-2026) & (K Units) Table 153. Middle East and Africa Gene Therapy Products Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Gene Therapy Products Sales Forecast by Country (2027-2032) & (K Units) Table 155. Middle East and Africa Gene Therapy Products Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Gene Therapy Products Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Gene Therapy Products Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Gene Therapy Products Market Share by Country (2021-2026) Table 159. Middle East and Africa Gene Therapy Products Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Gene Therapy Products Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Gene Therapy Products Distributors List Table 164. Gene Therapy Products Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Gene Therapy Products Image Figure 2. Global Gene Therapy Products Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gene Therapy Products Market Size (2021-2032) & (US$ Million) Figure 4. Global Gene Therapy Products Sales (2021-2032) & (K Units) Figure 5. Ex vivo Image Figure 6. Global Ex vivo Sales YoY Growth (2021-2032) & (K Units) Figure 7. In Vivo Image Figure 8. Global In Vivo Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Gene Therapy Products Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Gene Therapy Products Market Share by Type 2025 VS 2032 Figure 11. North America Gene Therapy Products Sales Market Share in Volume by Type in 2025 Figure 12. North America Gene Therapy Products Sales Market Share in Value by Type in 2025 Figure 13. Europe Gene Therapy Products Sales Market Share in Volume by Type in 2025 Figure 14. Europe Gene Therapy Products Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Gene Therapy Products Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Gene Therapy Products Sales Market Share in Value by Type in 2025 Figure 17. Latin America Gene Therapy Products Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Gene Therapy Products Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Gene Therapy Products Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Gene Therapy Products Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Gene Therapy Products Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Cardiovascular disease Image Figure 24. Global Cardiovascular disease Sales YoY Growth (2021-2032) & (K Units) Figure 25. Monogenic Image Figure 26. Global Monogenic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Infectious disease Image Figure 28. Global Infectious disease Sales YoY Growth (2021-2032) & (K Units) Figure 29. Cancer Image Figure 30. Global Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 31. Other Image Figure 32. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Gene Therapy Products Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Gene Therapy Products Market Share by Application 2025 VS 2032 Figure 35. North America Gene Therapy Products Sales Market Share in Volume by Application in 2025 Figure 36. North America Gene Therapy Products Sales Market Share in Value by Application in 2025 Figure 37. Europe Gene Therapy Products Sales Market Share in Volume by Application in 2025 Figure 38. Europe Gene Therapy Products Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Gene Therapy Products Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Gene Therapy Products Sales Market Share in Value by Application in 2025 Figure 41. Latin America Gene Therapy Products Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Gene Therapy Products Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Gene Therapy Products Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Gene Therapy Products Sales Market Share in Value by Application in 2025 Figure 45. North America Gene Therapy Products Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Gene Therapy Products Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Gene Therapy Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Gene Therapy Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Gene Therapy Products Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Gene Therapy Products Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Gene Therapy Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Gene Therapy Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Gene Therapy Products Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Gene Therapy Products Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Gene Therapy Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Gene Therapy Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Gene Therapy Products Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Gene Therapy Products Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Gene Therapy Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Gene Therapy Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Gene Therapy Products Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Gene Therapy Products Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Gene Therapy Products Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Gene Therapy Products Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Gene Therapy Products Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Gene Therapy Products Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Ex vivo
  • In Vivo
Applications
  • Cardiovascular disease
  • Monogenic
  • Infectious disease
  • Cancer
  • Other
Companies covered
  • Advantagene
  • Avalanche Bio
  • Bluebird Bio
  • Celladon
  • Dimension Therapeutics
  • Sangamo
  • Spark Therapeutics
  • Vical Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Gene Therapy Products Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Gene Therapy Products Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Gene Therapy Products Market by Type
  6. 1.3.1 Ex vivo
  7. 1.3.2 In Vivo
  8. 1.4 Global Gene Therapy Products Market Size by Type
  9. 1.4.1 Global Gene Therapy Products Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Gene Therapy Products Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Gene Therapy Products Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Gene Therapy Products Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Gene Therapy Products Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Gene Therapy Products Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Gene Therapy Products Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Gene Therapy Products Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Gene Therapy Products Industry Trends
  2. 2.2 Gene Therapy Products Industry Drivers
  3. 2.3 Gene Therapy Products Industry Opportunities and Challenges
  4. 2.4 Gene Therapy Products Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Gene Therapy Products Revenue (2021-2026)
  2. 3.2 Global Top Players by Gene Therapy Products Sales (2021-2026)
  3. 3.3 Global Top Players by Gene Therapy Products Price (2021-2026)
  4. 3.4 Global Gene Therapy Products Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Gene Therapy Products Major Company Production Sites & Headquarters
  6. 3.6 Global Gene Therapy Products Company, Product Type & Application
  7. 3.7 Global Gene Therapy Products Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Gene Therapy Products Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Gene Therapy Products Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Gene Therapy Products Tier 1, Tier 2, and Tier 3
4 Gene Therapy Products Regional Status and Outlook
  1. 4.1 Global Gene Therapy Products Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Gene Therapy Products Historic Market Size by Region
  3. 4.2.1 Global Gene Therapy Products Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Gene Therapy Products Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Gene Therapy Products Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Gene Therapy Products Forecasted Market Size by Region
  7. 4.3.1 Global Gene Therapy Products Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Gene Therapy Products Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Gene Therapy Products Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Gene Therapy Products by Application
  1. 5.1 Gene Therapy Products Market by Application
  2. 5.1.1 Cardiovascular disease
  3. 5.1.2 Monogenic
  4. 5.1.3 Infectious disease
  5. 5.1.4 Cancer
  6. 5.1.5 Other
  7. 5.2 Global Gene Therapy Products Market Size by Application
  8. 5.2.1 Global Gene Therapy Products Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Gene Therapy Products Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Gene Therapy Products Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Gene Therapy Products Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Gene Therapy Products Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Gene Therapy Products Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Gene Therapy Products Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Gene Therapy Products Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Advantagene
  2. 6.1.1 Advantagene Company Information
  3. 6.1.2 Advantagene Business Overview
  4. 6.1.3 Advantagene Gene Therapy Products Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Advantagene Gene Therapy Products Product Portfolio
  6. 6.1.5 Advantagene Recent Developments
  7. 6.2 Avalanche Bio
  8. 6.2.1 Avalanche Bio Company Information
  9. 6.2.2 Avalanche Bio Business Overview
  10. 6.2.3 Avalanche Bio Gene Therapy Products Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Avalanche Bio Gene Therapy Products Product Portfolio
  12. 6.2.5 Avalanche Bio Recent Developments
  13. 6.3 Bluebird Bio
  14. 6.3.1 Bluebird Bio Company Information
  15. 6.3.2 Bluebird Bio Business Overview
  16. 6.3.3 Bluebird Bio Gene Therapy Products Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Bluebird Bio Gene Therapy Products Product Portfolio
  18. 6.3.5 Bluebird Bio Recent Developments
  19. 6.4 Celladon
  20. 6.4.1 Celladon Company Information
  21. 6.4.2 Celladon Business Overview
  22. 6.4.3 Celladon Gene Therapy Products Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Celladon Gene Therapy Products Product Portfolio
  24. 6.4.5 Celladon Recent Developments
  25. 6.5 Dimension Therapeutics
  26. 6.5.1 Dimension Therapeutics Company Information
  27. 6.5.2 Dimension Therapeutics Business Overview
  28. 6.5.3 Dimension Therapeutics Gene Therapy Products Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Dimension Therapeutics Gene Therapy Products Product Portfolio
  30. 6.5.5 Dimension Therapeutics Recent Developments
  31. 6.6 Sangamo
  32. 6.6.1 Sangamo Company Information
  33. 6.6.2 Sangamo Business Overview
  34. 6.6.3 Sangamo Gene Therapy Products Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sangamo Gene Therapy Products Product Portfolio
  36. 6.6.5 Sangamo Recent Developments
  37. 6.7 Spark Therapeutics
  38. 6.7.1 Spark Therapeutics Company Information
  39. 6.7.2 Spark Therapeutics Business Overview
  40. 6.7.3 Spark Therapeutics Gene Therapy Products Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Spark Therapeutics Gene Therapy Products Product Portfolio
  42. 6.7.5 Spark Therapeutics Recent Developments
  43. 6.8 Vical Inc.
  44. 6.8.1 Vical Inc. Company Information
  45. 6.8.2 Vical Inc. Business Overview
  46. 6.8.3 Vical Inc. Gene Therapy Products Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Vical Inc. Gene Therapy Products Product Portfolio
  48. 6.8.5 Vical Inc. Recent Developments
7 North America by Country
  1. 7.1 North America Gene Therapy Products Sales by Country
  2. 7.1.1 North America Gene Therapy Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Gene Therapy Products Sales by Country (2021-2026)
  4. 7.1.3 North America Gene Therapy Products Sales Forecast by Country (2027-2032)
  5. 7.2 North America Gene Therapy Products Market Size by Country
  6. 7.2.1 North America Gene Therapy Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Gene Therapy Products Market Size by Country (2021-2026)
  8. 7.2.3 North America Gene Therapy Products Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Gene Therapy Products Sales by Country
  2. 8.1.1 Europe Gene Therapy Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Gene Therapy Products Sales by Country (2021-2026)
  4. 8.1.3 Europe Gene Therapy Products Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Gene Therapy Products Market Size by Country
  6. 8.2.1 Europe Gene Therapy Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Gene Therapy Products Market Size by Country (2021-2026)
  8. 8.2.3 Europe Gene Therapy Products Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Gene Therapy Products Sales by Country
  2. 9.1.1 Asia-Pacific Gene Therapy Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Gene Therapy Products Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Gene Therapy Products Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Gene Therapy Products Market Size by Country
  6. 9.2.1 Asia-Pacific Gene Therapy Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Gene Therapy Products Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Gene Therapy Products Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Gene Therapy Products Sales by Country
  2. 10.1.1 South America Gene Therapy Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Gene Therapy Products Sales by Country (2021-2026)
  4. 10.1.3 South America Gene Therapy Products Sales Forecast by Country (2027-2032)
  5. 10.2 South America Gene Therapy Products Market Size by Country
  6. 10.2.1 South America Gene Therapy Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Gene Therapy Products Market Size by Country (2021-2026)
  8. 10.2.3 South America Gene Therapy Products Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Gene Therapy Products Sales by Country
  2. 11.1.1 Middle East and Africa Gene Therapy Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Gene Therapy Products Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Gene Therapy Products Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Gene Therapy Products Market Size by Country
  6. 11.2.1 Middle East and Africa Gene Therapy Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Gene Therapy Products Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Gene Therapy Products Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Gene Therapy Products Value Chain Analysis
  2. 12.1.1 Gene Therapy Products Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Gene Therapy Products Production Mode & Process
  7. 12.2 Gene Therapy Products Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Gene Therapy Products Distributors
  10. 12.2.3 Gene Therapy Products Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst